Steven Delco

Steven Delco has worked in the life sciences industry for over 30 years as an educator, scientist, securities analyst, hedge fund manager, and CEO. In 1982 he founded the first biotech market research firm and in 1996 began publishing Biovest, one of the first biotech investment newsletters. Delco excelled in working for several leading investment firms on Wall Street. Recognized internationally as a thought leader at the intersection of biotechnology and finance, he has been quoted in the Wall Street Journal, Bloomberg Online, Reuters and is a regular contributor to Forbes.com. Currently he is the President and CEO of Delco Advisors LLC and President of Survive Cancer, Inc.